PROBACLAC NL-308
Natural health product licensed in Canada
- Other names
- Probaclac BV, Probaclac bacterial vaginosis, Probaclac vaginose bactérienne
- Licence holder
- Les laboratoires Nicar inc.
- NPN or DIN-HM
- 80041302
- Status
- Active licence
- Licence date
- 28 March 2013
- Revision date
- 13 February 2026
- Form
- Capsule
- Route of administration
- Vaginale
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Lactobacillus rhamnosus Source : A-119 | 6.8 Milliards d'UFC |
Non-medicinal ingredients
Dioxyde de titane, Lactose, Maltodextrine, Gélatine, Stéarate de magnésium, Acide ascorbique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Sexe féminin | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Pourrait aider à réduire la récurrence de la vaginose bactérienne.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80041302
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.